首頁 > 市場調查報告書 > 醫療設備

體外診斷

敗血症診斷市場規模、佔有率和成長分析（按技術、應用、產品、方法、病原體類型、檢測類型、最終用戶和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1899574

敗血症診斷市場規模、佔有率和成長分析（按技術、應用、產品、方法、病原體類型、檢測類型、最終用戶和地區分類）—2026-2033年產業預測

Sepsis Diagnostics Market Size, Share, and Growth Analysis, By Technology (Blood Culture Technology), By Application, By Product, By Method, By Pathogen Type, By Test Type, By End Users, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，敗血症診斷市場規模將達到 7.5 億美元，到 2025 年將達到 8.2 億美元，到 2033 年將達到 15.9 億美元，在預測期（2026-2033 年）內複合年成長率為 8.7%。

敗血症診斷市場是醫療保健領域的重要組成部分，其重點在於識別和管理敗血症，主要促進因素是感染疾病導致的住院人數不斷上升，尤其是在老年人和免疫力缺乏等弱勢群體中。多重檢測和快速PCR檢測等技術進步顯著提高了檢測的準確性和速度。醫療機構的支持性管理方案和指南也進一步推動了市場成長。然而，挑戰依然存在，例如先進診斷檢測的高成本限制了資源匱乏地區的可及性，以及診斷的複雜性可能導致延誤和誤診。此外，檢測通訊協定的差異性也會阻礙創新技術的應用。儘管如此，生物標記開發、快速檢測解決方案以及機器學習和人工智慧在診斷領域的應用仍有許多機會。

敗血症診斷市場促進因素

全球敗血症診斷市場的主要促進因素是敗血症盛行率的不斷上升，敗血症通常與高死亡率和巨大的醫療成本有關。醫療專業人員對早期診斷和治療的認知不斷提高，推動了對能夠快速識別敗血症的先進診斷工具的需求。此外，抗生素抗藥性的日益嚴重以及人口老化導致感染疾病風險增加，也加劇了對有效敗血症管理解決方案的需求。這些因素共同推動了膿毒症診斷技術的創新和投資，進一步促進了市場成長。

限制敗血症診斷市場的因素

由於敗血症相關症狀廣泛且特異性，早期診斷十分困難，因此敗血症診斷市場面臨嚴峻挑戰。這種複雜性可能導致治療延誤和誤診，最終降低診斷工具的有效性。此外，準確診斷膿毒症通常需要結合多種檢測方法，這進一步增加了診斷過程的複雜性，並延長了結果報告時間。這些因素阻礙了市場成長，因為它們可能導致醫療成本增加，並最終影響患者的治療效果。膿毒症的複雜性給臨床醫生和診斷公司都帶來了挑戰。

膿毒症診斷市場趨勢

敗血症診斷市場正經歷強勁成長，主要得益於分子診斷技術的進步，尤其是次世代定序(NGS) 和聚合酵素鏈鎖反應(PCR) 技術的應用。這些創新方法能夠快速且準確地識別病原體，與傳統培養方法相比，顯著縮短了診斷時間。這種快速檢測能力對於及時干預膿毒症治療至關重要，最終有助於改善患者預後。對早期診斷和個人化醫療的日益重視進一步推動了對這些先進診斷解決方案的需求，使其在全球醫療機構的敗血症管理策略中佔據核心地位。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

BioMerieux SA（France）
Becton, Dickinson and Company（BD）（USA）
Thermo Fisher Scientific, Inc.（USA）
F. Hoffmann-La Roche AG（Switzerland）
Danaher Corporation（Beckman Coulter, Inc.）（USA）
Bruker Corporation（USA）
Abbott Laboratories, Inc.（USA）
Cepheid（USA）
Luminex Corporation（USA）
T2 Biosystems, Inc.（USA）
Siemens Healthineers（Germany）
Qiagen NV（Netherlands）
Immunexpress, Inc.（USA）
Seegene Inc.（South Korea）
Koninklijke Philips NV（Netherlands）
GenMark Diagnostics（USA）
Wolters Kluwer NV.（Netherlands）
Epic Systems Corporation.（USA）
McKesson Corporation.（USA）

結論與建議

簡介目錄

Product Code: SQMIG35A2237

Sepsis Diagnostics Market size was valued at USD 0.75 Billion in 2024 and is poised to grow from USD 0.82 Billion in 2025 to USD 1.59 Billion by 2033, growing at a CAGR of 8.7% during the forecast period (2026-2033).

The sepsis diagnostics market is a crucial component of healthcare focused on identifying and managing sepsis, primarily driven by increased hospitalizations due to infections among vulnerable populations, such as the elderly and immunocompromised individuals. Technological advancements, including multiplex assays and rapid PCR tests, significantly enhance detection accuracy and speed. Supportive regulatory initiatives and guidelines from healthcare organizations further stimulate market growth. However, challenges persist, such as high costs of advanced diagnostic tests limiting accessibility in resource-constrained settings, and complexities in diagnosis leading to potential delays or misdiagnoses. Additionally, fluctuating testing protocols can hinder the adoption of innovative technologies. Nonetheless, opportunities abound in the development of biomarkers, rapid testing solutions, and the integration of machine learning and artificial intelligence in diagnostics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Sepsis Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Sepsis Diagnostics Market Segments Analysis

Global Sepsis Diagnostics Market is segmented by Technology, Application, Product, Method, Pathogen Type, Test Type, End Users and region. Based on Technology, the market is segmented into Blood Culture Technology. Based on Application, the market is segmented into Hospitals and Diagnostics Centres. Based on Product, the market is segmented into Blood Culture Media, Assays and Reagent Kits, Instruments and Software. Based on Method, the market is segmented into Conventional Diagnostics and Automated Diagnostics. Based on Pathogen Type, the market is segmented into Bacterial Sepsis and Other Pathogen Types. Based on Test Type, the market is segmented into Laboratory Tests andPoint-Of-Care Tests. Based on End Users, the market is segmented into Hospitals And Speciality Clinics, Pathology and Reference Laboratories, Research Laboratories and Academic Institute. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Sepsis Diagnostics Market

A key market driver for the global sepsis diagnostics market is the increasing prevalence of sepsis, which is often associated with high mortality rates and significant healthcare costs. The growing awareness among healthcare professionals regarding early diagnosis and treatment is fostering the demand for advanced diagnostic tools that can swiftly identify septic conditions. Furthermore, the rise in antibiotic resistance and the expanding aging population, who are more susceptible to infections, have amplified the need for effective sepsis management solutions. This convergence of factors is propelling innovation and investment in sepsis diagnostic technologies, further enhancing market growth.

Restraints in the Sepsis Diagnostics Market

The sepsis diagnostics market faces significant challenges due to the wide array of non-specific symptoms associated with sepsis, making early diagnosis complicated. This complexity can lead to delays in treatment or misdiagnosis, ultimately diminishing the effectiveness of diagnostic tools. Additionally, accurately diagnosing sepsis often requires a combination of various tests, which further complicates the diagnostic process and extends result turnaround times. These factors collectively hinder market growth, as they can lead to increased healthcare costs and ultimately impact patient outcomes. The intricate nature of sepsis complicates the landscape for both clinicians and diagnostic companies alike.

Market Trends of the Sepsis Diagnostics Market

The Sepsis Diagnostics market is witnessing a robust trend towards advancements in molecular diagnostics, particularly through the adoption of next-generation sequencing (NGS) and polymerase chain reaction (PCR) technologies. These innovative methods facilitate rapid and precise pathogen identification, drastically minimizing the time required for diagnosis compared to traditional culture techniques. This swift detection capability is crucial for timely intervention in sepsis treatment, ultimately improving patient outcomes. The growing focus on early diagnosis and personalized medicine is further driving the demand for these advanced diagnostic solutions, positioning them at the forefront of sepsis management strategies in healthcare settings globally.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Sepsis Diagnostics Market Size by Technology & CAGR (2026-2033)

Market Overview
Blood Culture Technology

Global Sepsis Diagnostics Market Size by Application & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostics Centres

Global Sepsis Diagnostics Market Size by Product & CAGR (2026-2033)

Market Overview
Blood Culture Media
Assays and Reagent Kits
Instruments
Software

Global Sepsis Diagnostics Market Size by Method & CAGR (2026-2033)

Market Overview
Conventional Diagnostics
Automated Diagnostics

Global Sepsis Diagnostics Market Size by Pathogen Type & CAGR (2026-2033)

Market Overview
Bacterial Sepsis
- Gram-Negative Bacterial Sepsis
- Gram-Positive Bacterial Sepsis Fungal Sepsis
Other Pathogen Types

Global Sepsis Diagnostics Market Size by Test Type & CAGR (2026-2033)

Market Overview
Laboratory Tests
Point-Of-Care Tests

Global Sepsis Diagnostics Market Size by End Users & CAGR (2026-2033)

Market Overview
Hospitals And Speciality Clinics
Pathology and Reference Laboratories
Research Laboratories
Academic Institute

Global Sepsis Diagnostics Market Size & CAGR (2026-2033)

North America (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
- US
- Canada
Europe (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
- Brazil
- Rest of Latin America
Middle East & Africa (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

BioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (Beckman Coulter, Inc.) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cepheid (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
T2 Biosystems, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Immunexpress, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seegene Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenMark Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wolters Kluwer NV. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Epic Systems Corporation. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
McKesson Corporation. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments